Pivotal Bio Venture Partners Investment Advisor LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $71.5 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcutis Biotherapeutics, Inc. with a value of $33.2M, Vaxcyte, Inc. with a value of $26.8M, Inozyme Pharma, Inc. with a value of $4.09M, Recursion Pharmaceuticals, Inc. with a value of $3.15M, and Rallybio Corp with a value of $1.56M.

Examining the 13F form we can see an decrease of $37.2M in the current position value, from $109M to 71.5M.

Pivotal Bio Venture Partners Investment Advisor LLC is based out at San Francisco, CA

Below you can find more details about Pivotal Bio Venture Partners Investment Advisor LLC portfolio as well as his latest detailed transactions.

Portfolio value $71.5 Million
Healthcare: $71.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $71.5 Million
  • Prior Value $109 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.